A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients
Clinical trial NCT05263869 · UNKNOWN
Trial details
- NCT number
- NCT05263869
- Sponsor
- Shanghai Miracogen Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2022-12-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.